NOX-A12

· TME Pharma AG

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NOX-A12, covering 2014-06-26 to 2017-05-22. Get the full timeline:

Most recent: Clinical Trial Update: NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 2]